Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jana Matuskova"'
Autor:
Vandana S. Dole, Béatrice Cambien, Sophie Astrof, Crystal L. Piffath, Anil K. Chauhan, Jana Matuskova, Denisa D. Wagner, Richard O. Hynes
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 26:1391-1396
Objective— Plasma fibronectin (FN) is decreased in several clinical conditions. We were interested to study the thrombotic and hemostatic consequences of the decrease in plasma FN (pFN), the role of FN splice variants in thrombosis, and to examine
Autor:
Ayce Yesilaltay, Wolfgang Bergmeier, Monty Krieger, Eliza Vasile, Denisa D. Wagner, Michael Bernimoulin, Vandana S. Dole, Jana Matuskova
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology. 28(6)
Objective— High-density lipoprotein (HDL) receptor, scavenger receptor class B, type I (SR-BI), mediated cellular uptake of lipoprotein cholesterol controls HDL structure and plasma HDL and biliary cholesterol levels. In SR-BI knockout (KO) mice, a
Publikováno v:
Journal of thrombosis and haemostasis : JTH. 3(8)
The primary importance of tissue factor (TF) in blood coagulation and thrombus propagation has been recognized for many years. Nevertheless, our view about the origin of TF activity, necessary for normal hemostasis and found in pathologic conditions,
Publikováno v:
Blood. 104:2619-2619
In addition to von Willebrand factor and fibrinogen, plasma fibronectin (pFN) contributes significantly to thrombus development in arteries. Complete deficiency of plasma fibronectin (in pFN conditional knockout mice) affects thrombus formation and g